These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME): three new cases and review of the mutational spectrum. Najafi A; Tasharrofi B; Zandsalimi F; Rasulinezhad M; Ghahvechi Akbari M; Zamani G; Ashrafi MR; Heidari M Ital J Pediatr; 2023 Jun; 49(1):64. PubMed ID: 37280710 [TBL] [Abstract][Full Text] [Related]
8. Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy. Dyment DA; Sell E; Vanstone MR; Smith AC; Garandeau D; Garcia V; Carpentier S; Le Trionnaire E; Sabourdy F; Beaulieu CL; Schwartzentruber JA; McMillan HJ; ; Majewski J; Bulman DE; Levade T; Boycott KM Clin Genet; 2014 Dec; 86(6):558-63. PubMed ID: 24164096 [TBL] [Abstract][Full Text] [Related]
10. ASAH1-related disorders: Description of 15 novel pediatric patients and expansion of the clinical phenotype. Mahmoud IG; Elmonem MA; Zaki MS; Ramadan A; Al-Menabawy NM; El-Gamal A; Mansour L; Issa MY; Abdel-Hamid MS; Abdel-Hady S; Khalifa I; Ibrahim A; Solyom A; Rolfs A; Selim L Clin Genet; 2020 Dec; 98(6):598-605. PubMed ID: 32875576 [TBL] [Abstract][Full Text] [Related]
11. Five patients with spinal muscular atrophy-progressive myoclonic epilepsy (SMA-PME): a novel pathogenic variant, treatment and review of the literature. Karimzadeh P; Najmabadi H; Lochmuller H; Babaee M; Dehdahsi S; Miryounesi M; Amirsalari S; Rayegani SM; Tonekaboni SH Neuromuscul Disord; 2022 Oct; 32(10):806-810. PubMed ID: 36309462 [TBL] [Abstract][Full Text] [Related]
12. ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study. Filosto M; Aureli M; Castellotti B; Rinaldi F; Schiumarini D; Valsecchi M; Lualdi S; Mazzotti R; Pensato V; Rota S; Gellera C; Filocamo M; Padovani A Eur J Hum Genet; 2016 Nov; 24(11):1578-1583. PubMed ID: 27026573 [TBL] [Abstract][Full Text] [Related]
13. Clinical features and genetics in non-5q spinal muscular atrophy caused by acid ceramidase deficiency. Axente M; Shelby ES; Mirea A; Sporea C; Badina M; Padure L; Ion DA J Med Life; 2021; 14(3):424-428. PubMed ID: 34377212 [TBL] [Abstract][Full Text] [Related]
14. Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report. Lee BH; Mongiovi P; Levade T; Marston B; Mountain J; Ciafaloni E Am J Med Genet A; 2020 Oct; 182(10):2369-2371. PubMed ID: 32627310 [TBL] [Abstract][Full Text] [Related]
15. Whole-transcriptome sequencing in blood provides a diagnosis of spinal muscular atrophy with progressive myoclonic epilepsy. Kernohan KD; Frésard L; Zappala Z; Hartley T; Smith KS; Wagner J; Xu H; McBride A; Bourque PR; Consortium CRC; Bennett SAL; Dyment DA; Boycott KM; Montgomery SB; Warman Chardon J Hum Mutat; 2017 Jun; 38(6):611-614. PubMed ID: 28251733 [TBL] [Abstract][Full Text] [Related]
18. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content. Kyriakou K; Lederer CW; Kleanthous M; Drousiotou A; Malekkou A Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111095 [TBL] [Abstract][Full Text] [Related]
19. Functional analysis of a novel splice site variant in the ASAH1 gene. Yan S; Fu F; Zhou H; Huang R; Wang Y; Liao C Mol Genet Genomic Med; 2024 Jan; 12(1):e2317. PubMed ID: 37962265 [TBL] [Abstract][Full Text] [Related]